Anavex Life Sciences Corp. Will Present New Findings at the International Conference on Alzheimer’s Disease 2008 (July 26-31, 2008, Chicago, USA)

Athens, Greece — June 24, 2008 — Anavex Life Sciences Corp.  (“ANAVEX”) (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer’s Disease 2008 (July 26–31, 2008,Chicago,USA), where it will present results obtained with ANAVEX 1-41 demonstrating a protective effect against the neurotoxicity of amyloid β25-35 peptide (Aβ25-35) in mice.  This peptide is used…